Incidence and severity of SARS‐CoV‐2 reinfection, a multicenter cohort study in Shanghai, China
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28997 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Weien Yu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Department of Infectious Diseases, National Medical Center for Infec…. Hauptthemen laut MEDLINE: COVID-19, Pharyngitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Shanghai Rising-Star Program.
Abstract (Originalsprache)
During March 2022 to January 2023, two Omicron waves hit Shanghai and caused a massive number of reinfections. To better understand the incidence and clinical characteristics of SARS‐CoV‐2 reinfection in Shanghai, China, we conducted a multicenter cohort study. COVID‐19 patients first infected with BA.2 (March 1, 2022–May 23, 2022) who were quarantined in Huashan Hospital, Renji Hospital, and Shanghai Jing'an Central Hospital were followed up for reinfection from June 1, 2022 to January 31, 2023. Of 897 primary infections, 148 (16.5%) experienced reinfection. Incidence rate of reinfection was 0.66 cases per 1000 person‐days. Female gender (adjusted odds ratio [aOR]= 2.19, 95% confidence interval [CI]: 1.29–3.83) was a risk factor for reinfection. The four most common symptoms of reinfections during the circulation of BA.5 sublineages were cough (62.59%), sore throat (54.42%), fatigue (48.98%), and fever (42.57%). Having received a booster vaccination was not associated with reduced severity of reinfection in comparison with not having received booster vaccination. After matched 1:1 by age and sex, we found that reinfections with BA.5 sublineages had significantly lower occurrence and severity of fever, fatigue, sore throat, and cough, as compared to primary infections with BA.5 sublineages. SARS‐CoV‐2 Omicron reinfections were less severe than Omicron primary infections during the circulation of the same subvariant. Protection offered by both vaccination and previous infection was poor against SARS‐CoV‐2 reinfection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Department of Infectious Diseases, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
- Key Laboratory of Medical Molecular Virology (MOE/MOH), Shanghai Institute of Infectious Diseases and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China.
- Department of Infectious Diseases, Jing'An Branch of Huashan Hospital, Fudan University, Shanghai, China.
- Department of Infectious Diseases, Shanghai Jing'an Central Hospital, Fudan University, Shanghai, China.
- Department of Prevention and Health Care, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
ORCID-Profile: Weien Yu, Yuxian Huang, Zhongliang Shen, Jiming Zhang
Förderung
- Shanghai Rising-Star Program
Zitieren
APA
Yu, W., Guo, Y., Hu, T., Liu, Y., Fan, Q., Guo, L., Zheng, B., Kong, Y., Zhu, H., Yu, J., Chen, S., Zhang, Y., Wang, J., Li, F., Yang, F., Wang, Y., Zhu, Y., Huang, Y., Shen, Z., …, & Zhang, J. (2023). Incidence and severity of SARS‐CoV‐2 reinfection, a multicenter cohort study in Shanghai, China. Journal of Medical Virology. https://doi.org/10.1002/jmv.28997
Vancouver
Yu W, Guo Y, Hu T, Liu Y, Fan Q, Guo L, et al. Incidence and severity of SARS‐CoV‐2 reinfection, a multicenter cohort study in Shanghai, China. Journal of Medical Virology. 2023. doi:10.1002/jmv.28997
BibTeX
@article{Yu2023,
author = {Yu, Weien and Guo, Yue and Hu, Tiantian and Liu, Yuqi and Fan, Qingqi and Guo, Li and Zheng, Binrong and Kong, Yide and Zhu, Haoxiang and Yu, Jie and Chen, Shiqi and Zhang, Yongmei and Wang, Jinyu and Li, Fahong and Yang, Feifei and Wang, Yuee and Zhu, Yuzhen and Huang, Yuxian and Shen, Zhongliang and Ruan, Yi and Mao, Richeng and Zhang, Jiming},
title = {Incidence and severity of SARS‐CoV‐2 reinfection, a multicenter cohort study in Shanghai, China},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28997}
}
EUVIMED